98%
921
2 minutes
20
Aiming to lower intraocular pressure, trabeculectomy remains the gold standard procedure. This report describes a novel, cost-effective modified bleb-forming filtration technique, tFlow (tube flow shunt), utilizing sterile trimmed silicone tubes from the Ahmed Glaucoma Valve (AGV), model FP7, to construct a subconjunctival filtration pathway. Here, clinical outcomes are not reported and will be evaluated in a future study. While initial findings suggest it may provide a viable alternative to other modified bleb-forming filtration techniques involving commercial devices like PreserFlo MicroShunt, EX-PRESS Glaucoma Filtration Device, and XEN Gel Stent, further investigation is necessary. Additional patient inclusion and comparative studies with different bleb-forming filtration techniques are potential areas for future research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085971 | PMC |
http://dx.doi.org/10.7759/cureus.82399 | DOI Listing |
Cureus
April 2025
Department of Ophthalmology, Bangladesh Eye Hospital, Dhaka, BGD.
Aiming to lower intraocular pressure, trabeculectomy remains the gold standard procedure. This report describes a novel, cost-effective modified bleb-forming filtration technique, tFlow (tube flow shunt), utilizing sterile trimmed silicone tubes from the Ahmed Glaucoma Valve (AGV), model FP7, to construct a subconjunctival filtration pathway. Here, clinical outcomes are not reported and will be evaluated in a future study.
View Article and Find Full Text PDFCochrane Database Syst Rev
March 2023
Ophthalmology & Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Background: Glaucoma is an optic neuropathy that leads to visual field defects and vision loss. It is the second leading cause of irreversible blindness in the world. Treatment for glaucoma aims to reduce intraocular pressure (IOP) to slow or prevent further vision loss.
View Article and Find Full Text PDF